Skip to main content
. 2018 Dec 11;5(12):ofy303. doi: 10.1093/ofid/ofy303

Figure 4.

Figure 4.

Absolute benefit of various echocardiography strategies for 90-day survival compared with no echocardiography and treatment with short course therapy (NE2) for a patient with a VIRSTA score [3] of less than 3 points (risk of endocarditis 1.8%; 95% confidence interval, 1.0–3.6%) at a transesophageal echocardiography (TEE)-associated mortality risk of 0.01%. Boxes denote the 25th, 50th, and 75th percentile values, and the whiskers contain the 95% onfidence interval. TTE, transthoracic echocardiography.